Mr Faheez Mohamed
MD, MBChB, FRCS
Mr Faheez Mohamed graduated from the University of Edinburgh Medical School in 1996. He underwent Higher Surgical Training in the North East of England and was awarded Doctor of Medicine at The University of Newcastle in 2005 for his Thesis on intraperitoneal chemotherapy for the treatment of peritoneal malignancy. He is a Fellow of the Royal College of Surgeons of Edinburgh and of England. Mr Mohamed has been involved in extensive research into peritoneal malignancy under the supervision of Dr Paul Sugarbaker. He is currently Consultant Surgeon at the Peritoneal Malignancy Institute, Basingstoke.
Our medical advisors
Prof Wim P Ceelen
Prof Wim Ceelen is a senior GI surgeon at Ghent University Hospital, also an Associate Professor in surgical oncology at Ghent University.
Dr Aditi Bhatt
Aditi Bhatt is an Indian surgical oncologist who specializes in the
management of primary peritoneal malignancies and secondary peritoneal metastases of gastrointestinal and gynecological origin.
Dr Armando Sardi
Dr. Sardi is one of Maryland’s leading surgical oncologists who use Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat late stage, complex cancers of the abdominal region.
Professor Paul Moroz
Prof. Moroz advises Pseudomyxoma Survivor, as a specialist in pseudomyxoma peritonei and HIPEC treatment, based in Australia.
Laura Lambert MD
Laura Lambert, MD is a surgical oncologist who specializes in treating peritoneal surface malignancies including pseudomyxoma peritonei.
Mr Omer Aziz
Omer Aziz is a UK-based consultant colorectal surgeon at The Christie and a member of the Pseudomyxoma Survivor medical advisory board.